{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:00:45Z","timestamp":1762866045032,"version":"3.40.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,3]],"date-time":"2012-08-03T00:00:00Z","timestamp":1343952000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2369-13-76","type":"journal-article","created":{"date-parts":[[2012,8,3]],"date-time":"2012-08-03T10:14:00Z","timestamp":1343988840000},"source":"Crossref","is-referenced-by-count":7,"title":["Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism?"],"prefix":"10.1186","volume":"13","author":[{"given":"Jo\u00e3o M","family":"Fraz\u00e3o","sequence":"first","affiliation":[]},{"given":"Johann","family":"Braun","sequence":"additional","affiliation":[]},{"given":"Piergiorgio","family":"Messa","sequence":"additional","affiliation":[]},{"given":"Bastian","family":"Dehmel","sequence":"additional","affiliation":[]},{"given":"Caroline","family":"Mattin","sequence":"additional","affiliation":[]},{"given":"Martin","family":"Wilkie","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,8,3]]},"reference":[{"key":"342_CR1","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1046\/j.1523-1755.1999.07304.x","volume":"73","author":"E Slatopolsky","year":"1999","unstructured":"Slatopolsky E, Brown A, Dusso A: Pathogenesis of secondary hyperparathyroidism. Kidney Intl. 1999, 73: S14-19.","journal-title":"Kidney Intl"},{"issue":"11","key":"342_CR2","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G: Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Intl. 2006, 69 (11): 1945-1953. 10.1038\/sj.ki.5000414.","journal-title":"Kidney Intl"},{"issue":"4","key":"342_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"GA Block","year":"1998","unstructured":"Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998, 31 (4): 607-617. 10.1053\/ajkd.1998.v31.pm9531176.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"342_CR4","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","volume":"15","author":"GA Block","year":"2004","unstructured":"Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004, 15 (8): 2208-2218. 10.1097\/01.ASN.0000133041.27682.A2.","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"342_CR5","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","volume":"12","author":"SK Ganesh","year":"2001","unstructured":"Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK: Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol. 2001, 12 (10): 2131-2138.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"342_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","volume":"52","author":"F Tentori","year":"2008","unstructured":"Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RLRobinson BM, Port FK: Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2008, 52 (3): 519-530. 10.1053\/j.ajkd.2008.03.020.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"342_CR7","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","volume":"67","author":"EW Young","year":"2005","unstructured":"Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, Akizawa T, Kurokawa K, Bommer J, Piera L, Port FK: Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Intl. 2005, 67 (3): 1179-1187. 10.1111\/j.1523-1755.2005.00185.x.","journal-title":"Kidney Intl"},{"issue":"4 Suppl 3","key":"342_CR8","first-page":"1","volume":"42","author":"National Kidney Foundation","year":"2003","unstructured":"National Kidney Foundation: K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003, 42 (4 Suppl 3): 1-201.","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"342_CR9","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","volume":"87","author":"S Jono","year":"2000","unstructured":"Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM: Phosphate regulation of vascular smooth muscle cell calcification. Circulation Res. 2000, 87 (7): E10-17. 10.1161\/01.RES.87.7.e10.","journal-title":"Circulation Res"},{"issue":"2","key":"342_CR10","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000197562","volume":"27","author":"M Kanbay","year":"2009","unstructured":"Kanbay M, Goldsmith D, Akcay A, Covic A: Phosphate - the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review. Blood Purif. 2009, 27 (2): 220-230. 10.1159\/000197562.","journal-title":"Blood Purif"},{"issue":"6","key":"342_CR11","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1681\/ASN.2007070760","volume":"19","author":"S Mathew","year":"2008","unstructured":"Mathew S, Tustison KS, Sugatani T, Chaudhary LR, Rifas L, Hruska KA: The mechanism of phosphorus as a cardiovascular risk factor in CKD. J Am Soc Nephrol. 2008, 19 (6): 1092-1105. 10.1681\/ASN.2007070760.","journal-title":"J Am Soc Nephrol"},{"issue":"suppl. 113","key":"342_CR12","first-page":"S1","volume":"76","author":"K Disease","year":"2009","unstructured":"Disease K: Improving Global Outcomes (KDIGO) CKD\u2013MBD Work Group: KDIGO Clinical practice guidelines for the diagnosis, evaluation, prevention, and Treatment of Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD). Kidney Intl. 2009, 76 (suppl. 113): S1-S130.","journal-title":"Kidney Intl"},{"issue":"2","key":"342_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1172\/JCI100848","volume":"16","author":"TG Drake","year":"1937","unstructured":"Drake TG, Albright F, Castleman B: Parathyroid Hyperplasia in Rabbits Produced by Parenteral Phosphate Administration. J Clin Invest. 1937, 16 (2): 203-206. 10.1172\/JCI100848.","journal-title":"J Clin Invest"},{"key":"342_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1172\/JCI105117","volume":"44","author":"LG Raisz","year":"1965","unstructured":"Raisz LG: Bone Resorption in Tissue Culture. Factors Influencing the Response to Parathyroid Hormone. J Clin Invest. 1965, 44: 103-116. 10.1172\/JCI105117.","journal-title":"J Clin Invest"},{"issue":"2","key":"342_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ki.2008.130","volume":"74","author":"KA Hruska","year":"2008","unstructured":"Hruska KA, Mathew S, Lund R, Qiu P, Pratt R: Hyperphosphatemia of chronic kidney disease. Kidney Intl. 2008, 74 (2): 148-157. 10.1038\/ki.2008.130.","journal-title":"Kidney Intl"},{"issue":"5","key":"342_CR16","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1053\/j.ajkd.2010.02.340","volume":"55","author":"K Uhlig","year":"2010","unstructured":"Uhlig K, Berns JS, Kestenbaum B, Kumar R, Leonard MB, Martin KJ, Sprague SM, Goldfarb S: KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD). Am J Kidney Dis. 2010, 55 (5): 773-799. 10.1053\/j.ajkd.2010.02.340.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"342_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1159\/000073945","volume":"23","author":"SM Moe","year":"2003","unstructured":"Moe SM, Drueke TB: Management of secondary hyperparathyroidism: the importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product. AmJ Nephrol. 2003, 23 (6): 369-379. 10.1159\/000073945.","journal-title":"AmJ Nephrol"},{"issue":"6","key":"342_CR18","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1093\/ndt\/gfl006","volume":"21","author":"MD Arenas","year":"2006","unstructured":"Arenas MD, Alvarez-Ude F, Gil MT, Soriano A, Egea JJ, Millan I, Amoedo ML, Muray S, Carreton MA: Application of NKF-K\/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units. Nephrol Dial Transplant. 2006, 21 (6): 1663-1668. 10.1093\/ndt\/gfl006.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"342_CR19","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2215\/CJN.01060308","volume":"3","author":"MD Danese","year":"2008","unstructured":"Danese MD, Belozeroff V, Smirnakis K, Rothman KJ: Consistent control of mineral and bone disorder in incident hemodialysis patients. Clin J Am Soc Nephrol. 2008, 3 (5): 1423-1429. 10.2215\/CJN.01060308.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5 Suppl 3","key":"342_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0272-6386(04)01103-5","volume":"44","author":"EW Young","year":"2004","unstructured":"Young EW, Akiba T, Albert JM, McCarthy JT, Kerr PG, Mendelssohn DC, Jadoul M: Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004, 44 (5 Suppl 3): 34-38.","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"342_CR21","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1073\/pnas.95.7.4040","volume":"95","author":"EF Nemeth","year":"1998","unstructured":"Nemeth EF, Steffey ME, Hammerland LG, Hung BC, Van Wagenen BC, DelMar EG, Balandrin MF: Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Nat Acad Sci USA. 1998, 95 (7): 4040-4045. 10.1073\/pnas.95.7.4040.","journal-title":"Proc Nat Acad Sci USA"},{"issue":"4","key":"342_CR22","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1681\/ASN.V1341017","volume":"13","author":"WG Goodman","year":"2002","unstructured":"Goodman WG, Hladik GA, Turner SA, Blaisdell PW, Goodkin DA, Liu W, Barri YM, Cohen RM, Coburn JW: The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol. 2002, 13 (4): 1017-1024.","journal-title":"J Am Soc Nephrol"},{"issue":"15","key":"342_CR23","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1056\/NEJMoa031633","volume":"350","author":"GA Block","year":"2004","unstructured":"Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drueke TB, Goodman WG: Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. New Engl J Med. 2004, 350 (15): 1516-1525. 10.1056\/NEJMoa031633.","journal-title":"New Engl J Med"},{"issue":"3","key":"342_CR24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/01.ASN.0000050224.03126.AD","volume":"14","author":"LD Quarles","year":"2003","unstructured":"Quarles LD, Sherrard DJ, Adler S, Rosansky SJ, McCary LC, Liu W, Turner SA, Bushinsky DA: The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease. J Am Soc Nephrol. 2003, 14 (3): 575-583. 10.1097\/01.ASN.0000050224.03126.AD.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"342_CR25","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1681\/ASN.2004060512","volume":"16","author":"JS Lindberg","year":"2005","unstructured":"Lindberg JS, Culleton B, Wong G, Borah MF, Clark RV, Shapiro WB, Roger SD, Husserl FE, Klassen PS, Guo MD, Albizem MB, Coburn JW: Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study. J Am Soc Nephrol. 2005, 16 (3): 800-807. 10.1681\/ASN.2004060512.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"342_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2215\/CJN.03591006","volume":"3","author":"P Messa","year":"2008","unstructured":"Messa P, Macario F, Yaqoob M, Bouman K, Braun J, Von Albertini B, Brink H, Maduell F, Graf H, Frazao JM, Bos WJ, Torregrosa V, Saha H, Reichel H, Wilkie M, Zani VJ, Molemans B, Carter D, Locatelli F: The OPTIMA study: assessing a new cinacalcet (Sensipar\/Mimpara) treatment algorithm for secondary hyperparathyroidism. Clin J Am Soc Nephrol. 2008, 3 (1): 36-45. 10.2215\/CJN.03591006.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"342_CR27","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1523-1755.2005.00517.x","volume":"68","author":"KJ Martin","year":"2005","unstructured":"Martin KJ, Juppner H, Sherrard DJ, Goodman WG, Kaplan MR, Nassar G, Campbell P, Curzi M, Charytan C, McCary LC, Guo MD, Turner SA, Bushinsky DA: First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl. Kidney Int. 2005, 68 (3): 1236-1243. 10.1111\/j.1523-1755.2005.00517.x.","journal-title":"Kidney Int"},{"issue":"4","key":"342_CR28","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s11255-007-9254-2","volume":"39","author":"BS Peters","year":"2007","unstructured":"Peters BS, Moyses RM, Jorgetti V, Martini LA: Effects of parathyroidectomy on bone remodeling markers and vitamin D status in patients with chronic kidney disease-mineral and bone disorder. Int Urol Nephrol. 2007, 39 (4): 1251-1256. 10.1007\/s11255-007-9254-2.","journal-title":"Int Urol Nephrol"},{"issue":"7","key":"342_CR29","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1093\/ndt\/gfm931","volume":"23","author":"S Mazzaferro","year":"2008","unstructured":"Mazzaferro S, Pasquali M, Farcomeni A, Vestri AR, Filippini A, Romani AM, Barresi G, Pugliese F: Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K\/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients. Nephrol Dial Transplant. 2008, 23 (7): 2319-2323. 10.1093\/ndt\/gfm931.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"342_CR30","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00268-009-0057-8","volume":"33","author":"LC Conti-Freitas","year":"2009","unstructured":"Conti-Freitas LC, Foss-Freitas MC, Lucca LJ, da Costa JA, Mamede RC, Foss MC: Dynamics of parathyroid hormone secretion after total parathyroidectomy and autotransplantation. World J Surg. 2009, 33 (7): 1403-1407. 10.1007\/s00268-009-0057-8.","journal-title":"World J Surg"},{"issue":"6","key":"342_CR31","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1210\/jc.2009-1909","volume":"95","author":"K Wesseling-Perry","year":"2010","unstructured":"Wesseling-Perry K, Harkins GC, Wang HJ, Elashoff R, Gales B, Horwitz MJ, Stewart AF, Juppner H, Salusky IB: The calcemic response to continuous parathyroid hormone (PTH)(1\u201334) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7\u201384). J Clin Endocrinol Metab. 2010, 95 (6): 2772-2780. 10.1210\/jc.2009-1909.","journal-title":"J Clin Endocrinol Metab"},{"key":"342_CR32","doi-asserted-by":"crossref","unstructured":"Kilpatrick RD, Gill KS, Block GA: [SA-PO2403] Exploring the Relationship between Temporal Trends in PTH, P and Ca in HD Patients. [abstract presented at the American Society of Nephrology Annual Meeting Denver, Colorado, November 16-21, 2010]","DOI":"10.1681\/ASN.20102111S11"},{"issue":"3","key":"342_CR33","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000156717","volume":"29","author":"T Shigematsu","year":"2009","unstructured":"Shigematsu T, Akizawa T, Uchida E, Tsukamoto Y, Iwasaki M, Koshikawa S: Long-term cinacalcet HCl treatment improved bone metabolism in Japanese hemodialysis patients with secondary hyperparathyroidism. Am J Nephrol. 2009, 29 (3): 230-236. 10.1159\/000156717.","journal-title":"Am J Nephrol"},{"issue":"6","key":"342_CR34","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/sj.ki.5002769","volume":"73","author":"FC Barreto","year":"2008","unstructured":"Barreto FC, Barreto DV, Moyses RM, Neves KR, Canziani ME, Draibe SA, Jorgetti V, Carvalho AB: K\/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients. Kidney Int. 2008, 73 (6): 771-777. 10.1038\/sj.ki.5002769.","journal-title":"Kidney Int"},{"issue":"8","key":"342_CR35","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1681\/ASN.2007010022","volume":"18","author":"KD Rudser","year":"2007","unstructured":"Rudser KD, de Boer IH, Dooley A, Young B, Kestenbaum B: Fracture risk after parathyroidectomy among chronic hemodialysis patients. J Am Soc Nephrol. 2007, 18 (8): 2401-2407. 10.1681\/ASN.2007010022.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"342_CR36","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1093\/ndt\/gfq304","volume":"26","author":"M Naves-Diaz","year":"2011","unstructured":"Naves-Diaz M, Passlick-Deetjen J, Guinsburg A, Marelli C, Fernandez-Martin JL, Rodriguez-Puyol D, Cannata-Andia JB: Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study. Nephrol Dial Transplant. 2011, 26 (6): 1938-47. 10.1093\/ndt\/gfq304.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"342_CR37","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","volume":"26","author":"J Floege","year":"2010","unstructured":"Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A, Kronenberg F, Marcelli D, Passlick-Deetjen J, Schernthaner G, Fouqueray B, Wheeler DC: Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant. 2010, 26 (6): 1948-55.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"342_CR38","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1093\/ndt\/gfp762","volume":"25","author":"J Floege","year":"2010","unstructured":"Floege J, Raggi P, Block GA, Torres PU, Csiky B, Naso A, Nossuli K, Moustafa M, Goodman WG, Lopez N, Downey G, Dehmel B, Chertow GM: Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in haemodialysis patients. Nephrol Dial Transplant. 2010, 25 (6): 1916-1923. 10.1093\/ndt\/gfp762.","journal-title":"Nephrol Dial Transplant"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-13-76\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-76.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-76","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-76.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T13:43:23Z","timestamp":1743947003000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-13-76"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,3]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["342"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-13-76","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2012,8,3]]},"article-number":"76"}}